Dr. Leigh Beveridge
Senior Medical Director
University of California, Davis
San Francisco, California
About Dr. Leigh Beveridge
Dr Leigh Beveridge is a physician scientist and senior medical leader based in Victoria, Australia. He works in drug development with a focus on haematology, oncology and immunology. His career centres on late stage clinical trials and the development of new therapies for blood and immune diseases.
Beveridge currently works as a Senior Medical Director and Drug Development Physician. He has led global programmes in haematologic diseases, including work on complement inhibition and autoimmune haematology. At Servier, he oversaw development of pegylated asparaginase for acute lymphoblastic leukaemia and supported regulatory submissions and paediatric extensions. At Genentech, he served as Lead Medical Director in Product Development Haematology, working on rare blood disorders and pivotal clinical studies.
Earlier in his career, Beveridge trained and practised in internal medicine and haematology in Melbourne. He held roles as Haematology Fellow and Physician at Alfred Health and Monash Health, Clinical Haematology Physician at Epworth, and Internal Medicine Physician with Healthcare Australia. These roles provided a clinical base that informs his work in industry.
Beveridge holds an MBBS from the University of Tasmania and studied biomedical science at Monash University. He completed a Master of Medicine and an Advanced Master of Medicine in Pharmaceutical and Medical Device Development at the University of Sydney. He also completed an MBA at the University of California, Davis, where he is a member of Beta Gamma Sigma.
He serves as a Graduate Teaching Assistant in the UC Davis Online MBA programme, mentoring students in articulation and critical thinking and linking medical practice with management training.
Areas of Focus
Career Background
Education
Media
Press
Dr Leigh Beveridge (Australia) Calls for Better Science Communication & Inclusive Leadership Following New Feature Interview
Read the full article ›Dr Leigh Beveridge Australia Calls for Clearer Science and Smarter Leadership
Read the full article ›Awards & Recognition
Dean’s Honour Roll, Monash University
Dean’s Honour Roll, University of Tasmania
Award for Clinical Excellence, University of Tasmania
Award for Internal Medicine, University of Tasmania
Award for Psychiatry, University of Tasmania, date not specified
Undergraduate Opportunity Research Program Scholarship, University of Tasmania
Beta Gamma Sigma Honour Society Membership, University of California Davis, Nov 2025
Charities & Volunteering
Lifeline Australia, Volunteer Telephone Counsellor
JOYFM Melbourne, Volunteer Radio Presenter
San Francisco AIDS Foundation, Event Volunteer
American Diabetes Association, Type 1 Diabetes Mentor and Volunteer
Boards & Memberships
Beta Gamma Sigma, Member, Nov 2025 – present
Frequently Asked Questions
What does Dr. Leigh Beveridge do?
Dr. Leigh Beveridge is a Senior Medical Director and physician scientist working in drug development, with a focus on haematology, oncology and immunology. His career centres on late-stage clinical trials and developing new therapies for blood and immune diseases.
What is Dr. Leigh Beveridge known for?
He is known for leading global drug development programmes in haematologic diseases, including work on complement inhibition and autoimmune haematology, and has been featured in press coverage calling for better science communication and inclusive STEM leadership.
Where is Dr. Leigh Beveridge based?
He is based in San Francisco, California, though his bio also notes ties to Victoria, Australia.
Where did Dr. Leigh Beveridge study?
He earned an MBBS from the University of Tasmania, a Bachelor of Science in biomedical science from Monash University, a Master of Medicine in Pharmaceutical and Medical Device Development from the University of Sydney, and an MBA from the University of California, Davis.
Who does Dr. Leigh Beveridge work for?
He works at the University of California, Davis, and has previously held senior medical director and lead medical director roles at Servier and Genentech.
Last updated February 20, 2026